![]()
|
|
||||||||
(Received for publication, April 17,
1995; and in revised form, July 11, 1995) To determine the basis for unexpected differences in CYP1A1
inducing potencies and efficacies for the diet-derived indole
derivative, indolo[3,2-b]carbazole (ICZ) and
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), we conducted a
systematic analysis of events involved in the induced expression of
CYP1A1 in murine hepatoma-derived cell lines (Hepa-1). In contrast to
the effects of TCDD, induction kinetics and CYP1A1 mRNA half-life were
dependent on ICZ concentration, and the response from low doses of
inducer was transient due to rapid clearance of ICZ. TCDD and ICZ
produced the same maximum response (i.e. equal efficacies)
from a TCDD-responsive CAT reporter construct in Hepa-1 cells. When
measured by the immediate responses associated with CYP1A1 expression,
including cellular uptake of inducer, receptor transformation and
binding to DRE (gel mobility shift assay), initiation of transcription
(nuclear run-on assay), and short-term accumulation of mRNA (Northern
blot assay), ICZ also exhibited an efficacy equal to that of TCDD and a
potency that corresponds to its receptor affinity. ICZ is a potent and
selective noncompetitive inhibitor of ethoxyresorufin O-deethylase activity (K
Volume 270,
Number 38,
Issue of September 22, pp. 22548-22555, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
3,2-b
carbazole in Murine Hepatoma
Cells
= 1.5 nM). Taken together these results
indicate that ICZ is a bifunctional modulator of CYP1A1 expression with
intrinsic efficacy equal to that of TCDD.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Anwar-Mohamed and A. O. S. El-Kadi Down-Regulation of the Carcinogen-Metabolizing Enzyme Cytochrome P450 1a1 by Vanadium Drug Metab. Dispos., September 1, 2008; 36(9): 1819 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki and K. Nohara Regulatory Factors Involved in Species-specific Modulation of Arylhydrocarbon Receptor (AhR)-dependent Gene Expression in Humans and Mice J. Biochem., October 1, 2007; 142(4): 443 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Bohonowych and M. S. Denison Persistent Binding of Ligands to the Aryl Hydrocarbon Receptor Toxicol. Sci., July 1, 2007; 98(1): 99 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Petersen, S. Krishnan, and E. D. Hudgens The Aryl Hydrocarbon Receptor Pathway and Sexual Differentiation of Neuroendocrine Functions Endocrinology, June 1, 2006; 147(6): s33 - s42. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Korashy and A. O. S. El-Kadi Regulatory Mechanisms Modulating the Expression of Cytochrome P450 1A1 Gene by Heavy Metals Toxicol. Sci., November 1, 2005; 88(1): 39 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oberg, L. Bergander, H. Hakansson, U. Rannug, and A. Rannug Identification of the Tryptophan Photoproduct 6-Formylindolo[3,2-b]carbazole, in Cell Culture Medium, as a Factor That Controls the Background Aryl Hydrocarbon Receptor Activity Toxicol. Sci., June 1, 2005; 85(2): 935 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Garcia, G. A. Brar, D. H. H. Nguyen, L. F. Bjeldanes, and G. L. Firestone Indole-3-Carbinol (I3C) Inhibits Cyclin-dependent Kinase-2 Function in Human Breast Cancer Cells by Regulating the Size Distribution, Associated Cyclin E Forms, and Subcellular Localization of the CDK2 Protein Complex J. Biol. Chem., March 11, 2005; 280(10): 8756 - 8764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Adachi, Y. Mori, S. Matsui, and T. Matsuda Comparison of Gene Expression Patterns between 2,3,7,8-Tetrachlorodibenzo-p-dioxin and a Natural Arylhydrocarbon Receptor Ligand, Indirubin Toxicol. Sci., July 1, 2004; 80(1): 161 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Lai, M. H. Wong, and C. K. C. Wong Modulation of AhR-Mediated CYP1A1 mRNA and EROD Activities by 17{beta}-Estradiol and Dexamethasone in TCDD-Induced H411E Cells Toxicol. Sci., March 1, 2004; 78(1): 41 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Firestone and L. F. Bjeldanes Indole-3-Carbinol and 3-3'-Diindolylmethane Antiproliferative Signaling Pathways Control Cell-Cycle Gene Transcription in Human Breast Cancer Cells by Regulating Promoter-Sp1 Transcription Factor Interactions J. Nutr., July 1, 2003; 133(7): 2448S - 2455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Herrmann, M. Seidelin, H. C. Bisgaard, and O. Vang Indolo[3,2-b]carbazole inhibits gap junctional intercellular communication in rat primary hepatocytes and acts as a potential tumor promoter Carcinogenesis, November 1, 2002; 23(11): 1861 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Gambone, J. M. Hutcheson, J. L. Gabriel, R. L. Beard, R. A.S. Chandraratna, K. J. Soprano, and D. R. Soprano Unique Property of Some Synthetic Retinoids: Activation of the Aryl Hydrocarbon Receptor Pathway Mol. Pharmacol., February 1, 2002; 61(2): 334 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leong, G. L. Firestone, and L. F. Bjeldanes Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-{alpha} expression Carcinogenesis, November 1, 2001; 22(11): 1809 - 1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Fowke, C. Longcope, and J. R. Hebert Brassica Vegetable Consumption Shifts Estrogen Metabolism in Healthy Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 773 - 779. [Abstract] [Full Text] |
||||
![]() |
H. P. Ciolino and G. C. Yeh The Steroid Hormone Dehydroepiandrosterone Inhibits CYP1A1 Expression in Vitro By a Post-transcriptional Mechanism J. Biol. Chem., December 3, 1999; 274(49): 35186 - 35190. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, M. Qi, D.-Z. Chen, A. Anderson, G.-Y. Yang, J. M. Arbeit, and K. J. Auborn Indole-3-Carbinol Prevents Cervical Cancer in Human Papilloma Virus Type 16 (HPV16) Transgenic Mice Cancer Res., August 1, 1999; 59(16): 3991 - 3997. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Chan, G. Yao, Y.-Z. Gu, and C. A. Bradfield Cross-talk between the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor Signaling Pathways. DEMONSTRATION OF COMPETITION AND COMPENSATION J. Biol. Chem., April 23, 1999; 274(17): 12115 - 12123. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Cover, S. J. Hsieh, S. H. Tran, G. Hallden, G. S. Kim, L. F. Bjeldanes, and G. L. Firestone Indole-3-carbinol Inhibits the Expression of Cyclin-dependent Kinase-6 and Induces a G1 Cell Cycle Arrest of Human Breast Cancer Cells Independent of Estrogen Receptor Signaling J. Biol. Chem., February 13, 1998; 273(7): 3838 - 3847. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Adachi, Y. Mori, S. Matsui, H. Takigami, J. Fujino, H. Kitagawa, C. A. Miller III, T. Kato, K. Saeki, and T. Matsuda Indirubin and Indigo Are Potent Aryl Hydrocarbon Receptor Ligands Present in Human Urine J. Biol. Chem., August 17, 2001; 276(34): 31475 - 31478. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |